InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（3 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Ali-Jackson Kamil, Directeur Juridique. Director active across 4 companies, notably Aclaris Therapeutics, Inc.. Cumulatively, 14 filings have been published. Split: 1 buy · 3 sells. Total volume traded: €317k. History available since 3 May 2021. The latest transaction was disclosed on 26 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Ali-Jackson Kamil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
2,500 股Common StockSEC:0000905148-26-003076:0
2,500 股@ US$29.170.012% mcap100.0% 占其流量Common StockSEC:0000905148-26-002724:0
5,750 股0Common StockSEC:0000905148-26-002529:0
2,500 股0Common StockSEC:0000905148-25-001935:0
25,000 股0Common StockSEC:0000905148-24-001651:0
25,000 股0Common StockSEC:0001140361-23-034284:0
18,750 股0Common StockSEC:0001140361-22-020303:0
3,875 股Common StockSEC:0001209191-22-001712:0
7,500 股0Common StockSEC:0001209191-21-066084:0
11,764 股@ US$8.50100.0% 占其流量Common StockSEC:0001140361-21-021497:0
标准退出：2021年9月13日 (T+90)
9,492 股@ US$21.957539.3% 占其流量Common StockSEC:0001209191-21-038442:0
33,189 股Common StockSEC:0001209191-21-037482:0
15,000 股@ US$10.6630.3% 占其流量Common StockSEC:0001209191-21-031038:0
15,000 股@ US$10.6630.3% 占其流量Common StockSEC:0001209191-21-030491:0
14 条申报中的 14 条
About Ali-Jackson Kamil
Ali-Jackson Kamil is the Legal Director at Aclaris Therapeutics, Inc. He oversees the legal affairs of the company.
